After successful PCI for AMI and 1 mo of DAPT, P2Y12 inhibitor monotherapy was noninferior to continued DAPT for adverse outcomes.
Where this comes from
- Record sourced from PubMed, PMID 41325612.
- Also identified by DOI 10.7326/ANNALS-25-04709-JC.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text].
Medical subject headings
- Purinergic P2Y Receptor Antagonists
- Percutaneous Coronary Intervention
- Platelet Aggregation Inhibitors
- Myocardial Infarction
- Dual Anti-Platelet Therapy